The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Inspirata
Stock and Other Ownership Interests - Elucid Bioimaging; Inspirata
Honoraria - AstraZeneca; Inspirata
Consulting or Advisory Role - AstraZeneca; Inspirata; Merck
Research Funding - Inspirata (Inst); Philips Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - IP Licensed by Elucid Bioimaging (Inst); IP licensed by Inspirata Inc. (Inst)
Intra and perinodular CT delta radiomic features associated with early response to predict overall survival (OS) in immunotherapy-treated non-small cell lung cancer (NSCLC): A multisite multi-agent study.
 
Prateek Prasanna
No Relationships to Disclose
 
Mohammadhadi Khorrami
No Relationships to Disclose
 
Amit Gupta
No Relationships to Disclose
 
Pradnya Dinkar Patil
No Relationships to Disclose
 
Monica Khunger
No Relationships to Disclose
 
Priya Velu
No Relationships to Disclose
 
Kaustav Bera
No Relationships to Disclose
 
Mehdi Alilou
No Relationships to Disclose
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - Alkermes; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Dr. Reddy's; Foundation Medicine; Genentech; Genoptix; Merck; Nektar; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Foundation Medicine; Merck
 
Anant Madabhushi
No Relationships to Disclose